Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults

European Journal of Endocrinology

Volumn 140, Issue 6, 1999, Pages 545-554

  Välimäki, Matti J ^a,g   Salmela, Pasi I ^b   Salmi, Jorma ^c   Viikari, Jorma ^d   Kataja, Matti ^e   Turunen, Heidi ^f   Soppi, Esa ^f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f Medical Department   (Finland)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GROWTH HORMONE; HUMAN GROWTH HORMONE; PROCOLLAGEN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CHILD; COLLAGEN; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; FEMALE; FEMUR; FOREARM; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; REGRESSION ANALYSIS;

EID: 18244420046     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400545     Document Type: Article

References (33)

1. Wusler C. Growth hormone and bone metabolism. Acta Endocrinologica 1993 128 (Suppl 2) 14-18.
2. Kaufman J-M, Taelman P, Vermeulen A & Vandeweghe M. Bone mineral status in growth-hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism 1992 74 118-123.
3. Holmes SJ, Economou G, Whitehouse RW, Adams JE & Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1994 78 669-674.
4. Rosen T, Hansson T, Granhed H, Szucs J & Bengtsson B-Å. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinologica 1993 129 201-206.
5. Johansson AG, Burman P, Wertermark K & Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. Journal of Internal Medicine 1992 232 447-452.
6. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G & Bengtsson B-Å. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology 1997 137 240-245.
7. Johansen JS, Pedersen SA, Jorgensen JOL, Riis BJ, Christiansen C, Christiansen JS et al. Effects of growth-hormone (GH) on plasma bone Gla protein in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1990 70 916-919.
8. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassager C & Christiansen C. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clinical Endocrinology 1991 35 471-476.
9. Bengtsson B-Å, Eden S, Lönn L, Kvist H, Stokland A, Lindstedt G et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 1993 76 309-317.
10. Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armenise P et al. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. European Journal of Endocrinology 1995 132 42-46.
11. Whitehead HM, Boreham C, McIlrath EM, Sheridans B, Kennedy L, Atkinson AB et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology 1992 36 45-52.
12. Amato G, Carella C, Fazio S, LaMontagna G, Cittadini A, Sabatini D et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism 1993 77 1671-1676.
13. Thoren M, Soop M, Degerblad M & Sääf M. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinologica 1993 128 (Suppl 2) 1-43.
14. Vandeweghe M, Taelman P & Kaufman J-M. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clinical Endocrinology 1993 39 409-415.
15. Juul A, Pedersen SA, Sorensen S, Winkler K, Jorgensen JOL, Christiansen JS et al. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. European Journal of Endocrinology 1994 131 41-49.
16. Rosen T, Johansson G, Hallgren P, Caidahl K, Bosaeus I & Bengtsson B-Å. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinology and Metabolism 1994 1 55-66.
17. Beshyah SA, Kyd P, Thomas E, Fairney A & Johnston DG. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clinical Endocrinology 1995 42 249-254.
18. Johansson G, Rosen T, Bosaeus I, Sjöström L & Bengtsson B-Å. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 2865-2873.
19. Baum HBA, Biller BMK, Finkelstein JS, Cannistraro KB, Oppenheim DS, Schoenfeld DA et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Annals of Internal Medicine 1996 125 883-890.
20. Bravenboer N, Holzmann P, De Boer H, Roos JC, Van Der Veen EA & Lips P. The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. Journal of Clinical Endocrinology and Metabolism 1997 82 1818-1822.
21. Degerblad M, Elgindy N, Hall K, Sjöberg H-E & Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinologica 1992 126 387-393.
22. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE & Shalet SM. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clinical Endocrinology 1995 42 627-633.
23. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE & Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. Journal of Clinical Endocrinology and Metabolism 1993 76 1344-1348.
24. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR et al. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. Journal of Bone and Mineral Research 1995 10 1844-1852.
25. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W et al. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clinical Endocrinology 1998 45 561-568.
26. Kanis JA, Melton LJ, Christiansen C, Johnston CC & Khaltaev N. Perspective. The diagnosis of osteoporosis. Journal of Bone and Mineral Research 1994 9 1137-1141.
27. Hoffman DM, O'Sullivan AJ, Baxter RC & Ho KK. Diagnosis of growth-hormone deficiency in adults. Lancet 1994 343 1046-1068.
28. Invited report of a workshop. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
29. Toogood AA, Beardwell CG & Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clinical Endocrinology 1994 41 511-516.
30. Ho KK & Weissberger JA. Secretory patterns of growth hormone according to sex and age. Hormone Research 1990 33 (Suppl 4) 7-11.
31. Lieberman SA, Mitchell AM, Marcus R, Hintz RI & Hoffman AR. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Hormone and Metabolic Research 1994 26 229-233.
32. Johansson G, Bjarnason R, Bramnert M, Carlsson LMS, Degerblad M, Manhem P et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. Journal of Clinical Endocrinology and Metabolism 1996 81 1575-1581.
33. Finkenstedt G, Gasser RW, Hofle G, Watfah C & Fridrich L. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset GH deficiency: results of a double-blind placebo-controlled study with open follow-up. European Journal of Endocrinology 1997 136 282-289.